Edgemont Partners Advises 3DR Laboratories on its Sale to Accumen, a Portfolio Company of Arsenal Capital Partners

Oct. 30, 2019

Edgemont Partners Advises 3DR Laboratories on its Sale to Accumen, a Portfolio Company of Arsenal Capital Partners

Oct. 22, 2019

91-3DR

Oct. 01, 2019

Physician practice market becoming a sellers’ market – 3 insights from Edgemont’s Jeff Swearingen

Aug. 06, 2019

Edgemont Partners Advises Laser & Skin Surgery Center of New York in Recapitalization with BelHealth and NavaDerm

Aug. 02, 2019

86-Laser & Skin Surgery Center of New York

Jul. 15, 2019

Pressure on Out of Network Billing: the Critical Issue in Healthcare Services M&A Valuations

By Jeff Swearingen and Saskia Siderow – Mergers and acquisitions in the healthcare services sector are hitting an…

Jul. 11, 2019

Edgemont Partners Advises Soderstrom Skin Institute and MedPro Advantage on a Strategic Transaction With H.I.G. Growth Partners

Jun. 24, 2019

84a-Soderstrom Skin Institute

Jun. 24, 2019

84b-MedPro Advantage

Jun. 17, 2019

Luke Mitchell on the past, present & future of GI PE investment

Jun. 05, 2019

Physician Groups Must Act on Value-Based Payment

By Jeff Swearingen and Saskia Siderow – For physician groups, the days of “practice as usual” are over….

May. 23, 2019

Jeff Swearingen on private equity’s impending impact in orthopedics